Rapid Eye Movement Sleep Behavior Disorder: Management and Prognostic Counseling.
Sleep Med Clin
; 19(1): 83-92, 2024 Mar.
Article
in En
| MEDLINE
| ID: mdl-38368072
ABSTRACT
Management of rapid eye movement sleep behavior disorder (RBD) includes reducing injurious dream-enactment behaviors, risk of injury to self and bedpartner, and vivid or disruptive dreams and improving sleep quality and bedpartner sleep disruption. Safety precautions should be reviewed at each visit. Medications to reduce RBD symptoms such as melatonin, clonazepam, pramipexole, and rivastigmine should be considered for most patients. Isolated RBD confers a high lifetime risk of neurodegenerative diseases with a latency often spanning many years. A patient-centered shared decision-making approach to risk disclosure is recommended. Knowledge of the risk allows for life planning and participation in research.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Neurodegenerative Diseases
/
REM Sleep Behavior Disorder
/
Melatonin
Limits:
Humans
Language:
En
Journal:
Sleep Med Clin
Year:
2024
Document type:
Article